Ghrelin-Cys(BMCC-biotinyl) (human) introduces a C-terminal cysteine conjugated via BMCC to a biotin tag, yielding a powerful affinity probe. The modified peptide maintains the native N-terminal acylation site while adding a handle for immobilization and detection. Researchers employ it in pull-down assays, receptor-binding studies, and imaging. Its dual functionalization supports advanced interaction mapping.
CAT No: G04016
Synonyms/Alias:Ghrelin-Cys(1-biotinamido-4-(4'-maleimido-N-methyl-cyclohexyl)carboxamido)butane) (human)
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More